Mineralys Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Mineralys Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mineralys Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mineralys Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.2M | 59k | 37.92 |
| 2025-06-30 | $330k | 24k | 13.53 |
| 2025-03-31 | $124k | 7.8k | 15.88 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas